177 related articles for article (PubMed ID: 24828489)
1. No chemopreventive effect of nonsteroidal anti-inflammatory drugs on nonmelanoma skin cancer: evidence from meta-analysis.
Zhang B; Liang X; Ye L; Wang Y
PLoS One; 2014; 9(5):e96887. PubMed ID: 24828489
[TBL] [Abstract][Full Text] [Related]
2. Effect of NSAIDs on the recurrence of nonmelanoma skin cancer.
Grau MV; Baron JA; Langholz B; Karagas M; Greenberg ER; Stukel TA; Mandel JS
Int J Cancer; 2006 Aug; 119(3):682-6. PubMed ID: 16496410
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer.
Reinau D; Surber C; Jick SS; Meier CR
Int J Cancer; 2015 Jul; 137(1):144-53. PubMed ID: 25418602
[TBL] [Abstract][Full Text] [Related]
4. Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial.
Clouser MC; Roe DJ; Foote JA; Harris RB
Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):276-83. PubMed ID: 19226541
[TBL] [Abstract][Full Text] [Related]
5. Aspirin and nonsteroidal anti-inflammatory drugs can prevent cutaneous squamous cell carcinoma: a systematic review and meta-analysis.
Muranushi C; Olsen CM; Pandeya N; Green AC
J Invest Dermatol; 2015 Apr; 135(4):975-983. PubMed ID: 25521453
[TBL] [Abstract][Full Text] [Related]
6. Aspirin and nonsteroidal anti-inflammatory drug use and keratinocyte cancers: a large population-based cohort study of skin cancer in Australia.
Pandeya N; Olsen CM; Thompson BS; Dusingize JC; Neale RE; Green AC; Whiteman DC;
Br J Dermatol; 2019 Oct; 181(4):749-760. PubMed ID: 30920641
[TBL] [Abstract][Full Text] [Related]
7. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.
Marcil I; Stern RS
Arch Dermatol; 2000 Dec; 136(12):1524-30. PubMed ID: 11115165
[TBL] [Abstract][Full Text] [Related]
8. The association between nonsteroidal anti-inflammatory drugs and skin cancer: Different responses in American and European populations.
Ma Y; Yu P; Lin S; Li Q; Fang Z; Huang Z
Pharmacol Res; 2020 Feb; 152():104499. PubMed ID: 31689521
[TBL] [Abstract][Full Text] [Related]
9. Analgesic and nonsteroidal anti-inflammatory use in relation to nonmelanoma skin cancer: a population-based case-control study.
Torti DC; Christensen BC; Storm CA; Fortuny J; Perry AE; Zens MS; Stukel T; Spencer SK; Nelson HH; Karagas MR
J Am Acad Dermatol; 2011 Aug; 65(2):304-312. PubMed ID: 21529996
[TBL] [Abstract][Full Text] [Related]
10. Intralesional 5-Fluorouracil for Treatment of Non-Melanoma Skin Cancer: A Systematic Review.
Maghfour J; Kuraitis D; Murina A
J Drugs Dermatol; 2021 Feb; 20(2):192-198. PubMed ID: 33538569
[TBL] [Abstract][Full Text] [Related]
11. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.
Karagas MR; McDonald JA; Greenberg ER; Stukel TA; Weiss JE; Baron JA; Stevens MM
J Natl Cancer Inst; 1996 Dec; 88(24):1848-53. PubMed ID: 8961975
[TBL] [Abstract][Full Text] [Related]
12. Can oral nonsteroidal antiinflammatory drugs play a role in the prevention of basal cell carcinoma? A systematic review and metaanalysis.
Muranushi C; Olsen CM; Green AC; Pandeya N
J Am Acad Dermatol; 2016 Jan; 74(1):108-119.e1. PubMed ID: 26433247
[TBL] [Abstract][Full Text] [Related]
13. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
[TBL] [Abstract][Full Text] [Related]
14. Personal history of psoriasis and risk of nonmelanoma skin cancer (NMSC) among women in the United States: A population-based cohort study.
Dai H; Li WQ; Qureshi AA; Han J
J Am Acad Dermatol; 2016 Oct; 75(4):731-735. PubMed ID: 27436157
[TBL] [Abstract][Full Text] [Related]
15. Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review.
Barton V; Armeson K; Hampras S; Ferris LK; Visvanathan K; Rollison D; Alberg AJ
Arch Dermatol Res; 2017 May; 309(4):243-251. PubMed ID: 28285366
[TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal anti-inflammatory drugs and risk of ovarian cancer: systematic review and meta-analysis of observational studies.
Baandrup L; Faber MT; Christensen J; Jensen A; Andersen KK; Friis S; Kjaer SK
Acta Obstet Gynecol Scand; 2013 Mar; 92(3):245-55. PubMed ID: 23240575
[TBL] [Abstract][Full Text] [Related]
17. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
18. Changing demographics and pathology of nonmelanoma skin cancer in the last 30 years.
Collins GL; Nickoonahand N; Morgan MB
Semin Cutan Med Surg; 2004 Mar; 23(1):80-3. PubMed ID: 15095919
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: a population-based case-control study.
Johannesdottir SA; Chang ET; Mehnert F; Schmidt M; Olesen AB; Sørensen HT
Cancer; 2012 Oct; 118(19):4768-76. PubMed ID: 22644960
[TBL] [Abstract][Full Text] [Related]
20. Oral therapy for nonmelanoma skin cancer in patients with advanced disease and large tumor burden: a review of the literature with focus on a new generation of targeted therapies.
Rudnick EW; Thareja S; Cherpelis B
Int J Dermatol; 2016 Mar; 55(3):249-58; quiz 256, 258. PubMed ID: 26566923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
